Paula R Trumbo

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Challenges with using chronic disease endpoints in setting dietary reference intakes
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, College Park, MD 20740, USA
    Nutr Rev 66:459-64. 2008
  2. doi request reprint Tolerable upper intake levels for trans fat, saturated fat, and cholesterol
    Paula R Trumbo
    Office of Nutrition, Labeling and Dietary Supplements, U S Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 69:270-8. 2011
  3. doi request reprint Perchlorate consumption, iodine status, and thyroid function
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, United States Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 68:62-6. 2010
  4. ncbi request reprint Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 65:78-87. 2007
  5. ncbi request reprint Are there adverse effects of lycopene exposure?
    Paula R Trumbo
    Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, MD 20740, USA
    J Nutr 135:2060S-1S. 2005
  6. doi request reprint How the US Food and Drug Administration evaluates the scientific evidence for health claims
    Kathleen C Ellwood
    Center for Food Safety and Applied Nutrition, Office of Nutrition, Labeling, and Dietary Supplements, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 68:114-21. 2010
  7. ncbi request reprint Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review
    Claudine J Kavanaugh
    Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Cancer 61:157-64. 2009
  8. ncbi request reprint The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer
    Claudine J Kavanaugh
    Rd, Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    J Natl Cancer Inst 99:1074-85. 2007
  9. ncbi request reprint Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, Food and Drug Administration, College Park, MD, USA
    Am J Clin Nutr 84:971-4. 2006
  10. doi request reprint Dietary reference intakes: cases of appropriate and inappropriate uses
    Paula R Trumbo
    U S Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 71:657-64. 2013

Detail Information

Publications15

  1. doi request reprint Challenges with using chronic disease endpoints in setting dietary reference intakes
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, College Park, MD 20740, USA
    Nutr Rev 66:459-64. 2008
    ..This article discusses the application of and challenges associated with using chronic disease endpoints in setting DRIs...
  2. doi request reprint Tolerable upper intake levels for trans fat, saturated fat, and cholesterol
    Paula R Trumbo
    Office of Nutrition, Labeling and Dietary Supplements, U S Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 69:270-8. 2011
    ....
  3. doi request reprint Perchlorate consumption, iodine status, and thyroid function
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, United States Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 68:62-6. 2010
    ....
  4. ncbi request reprint Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 65:78-87. 2007
    ....
  5. ncbi request reprint Are there adverse effects of lycopene exposure?
    Paula R Trumbo
    Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, MD 20740, USA
    J Nutr 135:2060S-1S. 2005
  6. doi request reprint How the US Food and Drug Administration evaluates the scientific evidence for health claims
    Kathleen C Ellwood
    Center for Food Safety and Applied Nutrition, Office of Nutrition, Labeling, and Dietary Supplements, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 68:114-21. 2010
    ..The process used by the FDA to review the scientific evidence for health claims and qualified health claims are described in this article...
  7. ncbi request reprint Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review
    Claudine J Kavanaugh
    Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Cancer 61:157-64. 2009
    ..FDA found no credible evidence to support health claims for calcium and a reduced risk of breast and prostate cancers. The agency did find limited evidence for the relationship between calcium intake and colorectal cancer risk...
  8. ncbi request reprint The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer
    Claudine J Kavanaugh
    Rd, Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    J Natl Cancer Inst 99:1074-85. 2007
    ..The FDA found very limited evidence to support an association between tomato consumption and reduced risks of prostate, ovarian, gastric, and pancreatic cancers...
  9. ncbi request reprint Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, Food and Drug Administration, College Park, MD, USA
    Am J Clin Nutr 84:971-4. 2006
    ..On the basis of this evidence-based review, the FDA concluded that no credible evidence exists for a health claim about the intake of lutein or zeaxanthin (or both) and the risk of age-related macular degeneration or cataracts...
  10. doi request reprint Dietary reference intakes: cases of appropriate and inappropriate uses
    Paula R Trumbo
    U S Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 71:657-64. 2013
    ..In this review, cases are described in which DRIs were applied correctly, as well as cases from the growing number of examples in which the wrong DRI was used or DRIs were used incorrectly. ..
  11. pmc Evidence needed to inform the next dietary reference intakes for iodine
    Paula R Trumbo
    Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, College Park, MD
    Adv Nutr 4:718-22. 2013
    ..This review discusses the basis for the current DRIs for iodine and the evidence that may be needed for considering and conducting the reevaluation of one or more of the DRIs. ..
  12. ncbi request reprint Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 64:357-63. 2006
    ..The agency concluded that the relationship between chromium picolinate intake and insulin resistance is highly uncertain...
  13. doi request reprint FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis
    Carolyn S Chung
    Office of Nutrition, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Pediatrics 130:e408-14. 2012
    ....
  14. doi request reprint Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease
    Crystal M Rasnake
    Nutrition Programs Staff, US Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 66:76-81. 2008
    ..However, these emerging biomarkers need to be validated as surrogate endpoints before they are used by CFSAN in the evaluation of a CVD health claim...
  15. ncbi request reprint The level of evidence for permitting a qualified health claim: FDA's review of the evidence for selenium and cancer and vitamin E and heart disease
    Paula R Trumbo
    Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, MD 20740, USA
    J Nutr 135:354-6. 2005
    ..The rationale for these conclusions is discussed below...